Pure Red Cell Aplasia: Successful Treatment with Cyclophosphamide

Overview

Journal Blut

Specialty Hematology

Date 1973 Jan 1

PMID 4539603

Citations 1

Authors

J Vilan

K Rhyner

A M Ganzoni

Affiliations

Soon will be listed here.

Citing Articles

[Kinetics and regulation of granulocytopoiesis (author's transl)].

Forrer P Klin Wochenschr. 1977; 55(6):247-58.

PMID: 139501 DOI: 10.1007/BF01484725.

References

Krantz S . The effect of erythropoietin on human bone marrow cells in vitro. Life Sci. 1965; 4(24):2393-7. DOI: 10.1016/0024-3205(65)90294-8. View

Schmid J, Kiely J, PEASE G, HARGRAVES M . ACQUIRED PURE RED CELL AGENESIS. REPORT OF 16 CASES AND REVIEW OF THE LITERATURE. Acta Haematol. 1963; 30:255-70. DOI: 10.1159/000208132. View

Krantz S . Studies on red cell aplasia. 3. Treatment with horse antihuman thymocyte gamma globulin. Blood. 1972; 39(3):347-60. View

Jepson J, Lowenstein L . Panhypoplasia of the bone marrow. I. Demonstration of a plasma factor with anti-erythropoietin-like activity. Can Med Assoc J. 1968; 99(3):99-101. PMC: 1924372. View

Kilbridge T, Fried W, Heller P . The mechanism by which plethora suppresses erythropoiesis. Blood. 1969; 33(1):104-13. View

Finch C, Deubelbeiss K, Cook J, Eschbach J, Harker L, FUNK D . Ferrokinetics in man. Medicine (Baltimore). 1970; 49(1):17-53. DOI: 10.1097/00005792-197001000-00002. View

WHITCOMB W, MOORE M, Rhoads J . Influence of polycythemic and anemic plasma on erythrocyte iron incorporation in the plethoric hypoxic mouse. J Lab Clin Med. 1969; 73(4):584-93. View

Barland P . The use of chemotherapeutic agents in the treatment of non-neoplastic diseases. J Chronic Dis. 1971; 23(12):829-42. DOI: 10.1016/0021-9681(71)90013-0. View

Safdar S, Krantz S, Brown E . Successful immunosuppressive treatment of erythroid aplasia appearing after thymectomy. Br J Haematol. 1970; 19(4):435-43. DOI: 10.1111/j.1365-2141.1970.tb06971.x. View

10.

Krantz S . Response of polycythemia vera marrow to erythropoietin in vitro. J Lab Clin Med. 1968; 71(6):999-1012. View

11.

Krantz S, Kao V . Studies on red cell aplasia. II. Report of a second patient with an antibody to erythroblast nuclei and a remission after immunosuppressive therapy. Blood. 1969; 34(1):1-13. View

12.

Field E, Caughi M, BLACKETT N, SMITHERS D . Marrow-suppressing factors in the blood in pure red-cell aplasia, thymoma and Hodgkin's disease. Br J Haematol. 1968; 15(1):101-10. DOI: 10.1111/j.1365-2141.1968.tb01516.x. View

13.

SCHOOLEY J, Garcia J, Cantor L, Havens V . A summary of some studies on erythropoiesis using anti-erythropoietin immune serum. Ann N Y Acad Sci. 1968; 149(1):266-80. DOI: 10.1111/j.1749-6632.1968.tb15161.x. View

14.

Cook J, Marsaglia G, Eschbach J, FUNK D, Finch C . Ferrokinetics: a biologic model for plasma iron exchange in man. J Clin Invest. 1970; 49(2):197-205. PMC: 322461. DOI: 10.1172/JCI106228. View

15.

Rhyner K, GANZONI A . Erythrokinetics: evaluation of red cell production by ferrokinetics and reticulocyte counts. Eur J Clin Invest. 1972; 2(2):96-101. DOI: 10.1111/j.1365-2362.1972.tb00576.x. View

16.

Krantz S, Kao V . Studies on red cell aplasia. I. Demonstration of a plasma inhibitor to heme synthesis and an antibody to erythroblast nuclei. Proc Natl Acad Sci U S A. 1967; 58(2):493-500. PMC: 335662. DOI: 10.1073/pnas.58.2.493. View

17.

Al-Mondhiry H, Zanjani E, SPIVACK M, ZALUSKY R, Gordon A . Pure red cell aplasia and thymoma: loss of serum inhibitor of erythropoiesis following thymectomy. Blood. 1971; 38(5):576-82. View

18.

Adamson J, Alexanian R, Martinez C, Finch C . Erythropoietin excretion in normal man. Blood. 1966; 28(3):354-64. View

19.

DEGOWIN R, HOFSTRA D, GURNEY C . A comparison of erythropoietin bioassays. Proc Soc Exp Biol Med. 1962; 110:48-51. DOI: 10.3181/00379727-110-27418. View

20.

Hirst E, Robertson T . The syndrome of thymoma and erythroblastopenic anemia. A review of 56 cases including 3 case reports. Medicine (Baltimore). 1967; 46(3):225-64. DOI: 10.1097/00005792-196705000-00001. View